BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) amended and restated its manufacturing and supply agreement with Novartis Vaccines and Diagnostics, Inc. for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE